266
Views
19
CrossRef citations to date
0
Altmetric
Reports

The effects of fractional microablative CO2 laser therapy on sexual function in postmenopausal women and women with a history of breast cancer treated with endocrine therapy

&
Pages 127-131 | Received 02 Dec 2017, Accepted 20 May 2018, Published online: 08 Jun 2018

References

  • MacBride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85:87–94. doi:10.4065/mcp.2009.0413.
  • Palma F, Volpe A, Villa P, Cagnacci A. Vaginal atrophy of women in postmenopause. Results from a multicentric observational study: the AGATA study. Maturitas. 2016;83:40–44. doi:10.1016/j.maturitas.2015.09.001.
  • Lester J, Pahouja G, Andersen B, Lustberg M. Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med. 2015;5:50–66. doi:10.3390/jpm5020050.
  • Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016;215:704–11. doi:10.1016/j.ajog.2016.07.045.
  • The American Cancer Society medical and editorial content team. Breast Cancer. American Cancer Society. https://www.cancer.org/cancer/breast-cancer.html. 2016.
  • Shifren JL, Gass ML. The North American menopause society recommendations for clinical care of midlife women. Menopause. 2014;21:1038–62. doi:10.1097/GME.0000000000000319.
  • Stuenkel CA, Davis SR, Gompel A, Lumsden MA, Murad MH, Pinkerton JV, Santen RJ. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:3975–4011. doi:10.1210/jc.2015-2236.
  • Sousa MS, Peate M, Jarvis S, Hickey M, Friedlander M. A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Ther Adv Med Oncol. 2017;9:269–85. doi:10.1177/1758834016687260.
  • Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, et al. American Cancer Society/American Society of Clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin. 2016;66:43–73. doi:10.3322/caac.21319.
  • Hutchinson-Colas J, Segal S. Genitourinary syndrome of menopause and the use of laser therapy. Maturitas. 2015;82:342–45. doi:10.1016/j.maturitas.2015.08.001.
  • Salvatore S, Leone Roberti Maggiore U, Athanasiou S, Origoni M, Candiani M, Calligaro A, Zerbinati N. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause. 2015;22:845–49. doi:10.1097/GME.0000000000000401.
  • Zerbinati N, Serati M, Origoni M, Candiani M, Iannitti T, Salvatore S, Marotta F, Calligaro A. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30:429–36. doi:10.1007/s10103-014-1677-2.
  • Salvatore S, Nappi RE, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M. Leone Roberti Maggiore U. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Climacteric. 2015;18:219–25. doi:10.3109/13697137.2014.975197.
  • Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, Saitta S, Calagna G. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015;80:296–301. doi:10.1016/j.maturitas.2014.12.006.
  • Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, Candiani M. Leone Roberti Maggiore U. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17:363–69. doi:10.3109/13697137.2014.899347.
  • Sokol ER, Karram MM. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause. 2016;23:1102–07. doi:10.1097/GME.0000000000000700.
  • Filippini M, Farinelli M.Use of the MonaLisa Touch® Treatment on Cancer Patients. State Hospital – Republic of San Marino, Republic of San Marino; 2014.
  • Pieralli A, Fallani MG, Becorpi A, Bianchi C, Corioni S, Longinotti M, Tredici Z, Guaschino S. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet. 2016;294:841–46. doi:10.1007/s00404-016-4118-6.
  • Palma F, Della Vecchia E, Cagnacci A. Medical and patient attitude towards vaginal atrophy: the AGATA study. Climacteric. 2016;19:553–57. doi:10.1080/13697137.2016.1240770.
  • Portman D, Shulman L, Yeaw J, Zeng S, Uzoigwe C, Maamari R, Iyer NN. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy. Menopause. 2015;22:1197–203. doi:10.1097/GME.0000000000000465.
  • Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women’s VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013;10:1790–99. doi:10.1111/jsm.12190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.